NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Yesol Kim
Washington University Saint Louis - St. Louis / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5722204
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Yesol Kim's MOST POPULAR ARTICLES
1-)
miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancerD Son, Y Kim, S Lim, HG Kang, DH Kim, JW Park, W Cheong, HK Kong, ...Cancer letters 454, 224-233, 2019692019
2-)
Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrestSJ Park, HK Kong, YS Kim, YS Lee, JH ParkAmerican journal of cancer research 5 (7), 2127, 2015352015
3-)
Autophagy inhibits cancer stemness in triple‐negative breast cancer via miR‐181a‐mediated regulation of ATG5 and/or ATG2BJW Park, Y Kim, S Lee, CW Oh, EJ Lee, JY Ko, JH ParkMolecular Oncology 16 (9), 1857-1875, 2022312022
4-)
miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancerYS Kim, SJ Park, YS Lee, HK Kong, JH ParkOncotarget 7 (27), 42261, 2016302016
5-)
Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancerS Lim, Y Kim, SB Lee, HG Kang, DH Kim, JW Park, D Chung, H Kong, ...Oncogenesis 9 (10), 91, 2020252020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept